Recommendation ID
DG30/2
Question

NICE noted advice from clinical experts that there is variability between the faecal immunochemical tests. This may affect the number of positive and negative results reported by the tests when a single threshold is used. It recommended further research to investigate the variability between technologies and encouraged the companies to make sure that results can be standardised for use in a symptomatic population.

Any explanatory notes
(if applicable)

N/A


Source guidance details

Comes from guidance
Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care
Number
DG30
Date issued
July 2017

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 31/07/2017